Additionally, to our knowledge, no prior studies have evaluated interactions between CR proxies and APOE-ε2 in relationship to longitudinal cognitive decline, although this is an important question given prior findings suggesting greater protective effects of CR on risk of MCI symptom onset among APOE-ε2 carriers relative to APOE-ε2 noncarriers [29]. The gene discussed is APOE; the disease is Mental deterioration.